US Stock MarketDetailed Quotes

Mereo BioPharma (MREO)

Watchlist
  • 0.3100
  • +0.0180+6.16%
Close Jun 17 15:59 ET
  • 0.3129
  • +0.0029+0.94%
Post 19:59 ET
49.48MMarket Cap-1.55P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Mereo BioPharma (MREO) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
0
500K
0
0
500K
0
0
0
0
0
Operating revenue
--0
--500K
--0
--0
--500K
--0
--0
--0
--0
--0
Cost of revenue
133K
0
0
132K
0
0
0
0
Gross profit
367K
0
0
368K
0
0
0
0
Operating expense
-21.29%8.67M
-15.51%38.62M
-46.14%7.92M
4.61%9.57M
-18.67%10.12M
16.92%11.02M
32.27%45.72M
76.61%14.7M
-0.79%9.15M
116.06%12.45M
Selling and administrative expenses
-44.73%4.02M
-12.96%23.01M
-34.97%4.2M
-2.55%6.05M
-30.17%5.49M
23.13%7.27M
43.48%26.43M
79.43%6.45M
8.67%6.2M
194.79%7.87M
-General and administrative expense
-44.73%4.02M
-12.96%23.01M
-34.97%4.2M
-2.55%6.05M
-30.17%5.49M
23.13%7.27M
43.48%26.43M
79.43%6.45M
8.67%6.2M
194.79%7.87M
Research and development costs
20.79%4.75M
-15.12%17.77M
-52.47%4.19M
34.70%4.27M
8.63%5.37M
-1.60%3.93M
20.16%20.93M
83.62%8.82M
-11.80%3.17M
33.24%4.95M
Other operating expenses
48.65%-95K
-30.38%-2.15M
17.88%-473K
-230.09%-746K
-101.90%-745K
61.22%-185K
-28.83%-1.65M
-638.46%-576K
-175.61%-226K
40.58%-369K
Operating profit
21.29%-8.67M
16.31%-38.26M
46.14%-7.92M
-4.61%-9.57M
21.62%-9.75M
-16.92%-11.02M
-68.47%-45.72M
-108.50%-14.7M
-1.80%-9.15M
-6,450.00%-12.45M
Net non-operating interest income expense
-35.91%307K
14.78%1.92M
-21.34%398K
-24.44%476K
147.81%565K
56.03%479K
322.80%1.67M
23.41%506K
5,827.27%630K
134.76%228K
Non-operating interest income
-50.38%327K
-28.54%2.17M
-52.21%421K
-48.73%504K
5.37%589K
6.81%659K
42.70%3.04M
15.47%881K
42.67%983K
49.87%559K
Non-operating interest expense
-88.89%20K
-81.39%255K
-93.87%23K
-92.07%28K
-92.75%24K
-41.94%180K
-52.45%1.37M
6.23%375K
-49.57%353K
-67.83%331K
Other net income (expense)
170.03%1.65M
-800.25%-5.54M
-97.65%168K
131.91%2.07M
-14,181.58%-5.43M
-1,523.64%-2.35M
137.45%791K
338.15%7.15M
-363.04%-6.48M
95.80%-38K
Gain on sale of security
170.03%1.65M
-800.25%-5.54M
-97.65%168K
131.91%2.07M
-14,181.58%-5.43M
-1,523.64%-2.35M
137.63%791K
338.47%7.15M
-363.04%-6.48M
95.80%-38K
Income before tax
47.86%-6.72M
3.18%-41.88M
-4.33%-7.35M
53.18%-7.02M
-19.27%-14.62M
-43.97%-12.89M
-44.19%-43.25M
26.92%-7.05M
-129.69%-15M
-599.89%-12.26M
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
47.86%-6.72M
3.18%-41.88M
-4.33%-7.35M
53.18%-7.02M
-19.27%-14.62M
-43.97%-12.89M
-46.79%-43.25M
22.65%-7.05M
-129.69%-15M
-599.89%-12.26M
Net income continuous Operations
47.86%-6.72M
3.18%-41.88M
-4.33%-7.35M
53.18%-7.02M
-19.27%-14.62M
-43.97%-12.89M
-46.79%-43.25M
22.65%-7.05M
-129.69%-15M
-599.89%-12.26M
Minority interest income
Net income attributable to the parent company
47.86%-6.72M
3.18%-41.88M
-4.33%-7.35M
53.18%-7.02M
-19.27%-14.62M
-43.97%-12.89M
-46.79%-43.25M
22.65%-7.05M
-129.69%-15M
-599.89%-12.26M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
47.86%-6.72M
3.18%-41.88M
-4.33%-7.35M
53.18%-7.02M
-19.27%-14.62M
-43.97%-12.89M
-46.79%-43.25M
22.65%-7.05M
-129.69%-15M
-599.89%-12.26M
Basic earnings per share
50.00%-0.05
16.67%-0.25
0.00%-0.05
50.00%-0.05
0.00%-0.1
-100.00%-0.1
-50.00%-0.3
0.00%-0.05
-100.00%-0.1
-617.77%-0.1
Diluted earnings per share
50.00%-0.05
16.67%-0.25
0.00%-0.05
50.00%-0.05
0.00%-0.1
-100.00%-0.1
-50.00%-0.3
0.00%-0.05
-100.00%-0.1
-617.77%-0.1
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 0500K00500K00000
Operating revenue --0--500K--0--0--500K--0--0--0--0--0
Cost of revenue 133K00132K0000
Gross profit 367K00368K0000
Operating expense -21.29%8.67M-15.51%38.62M-46.14%7.92M4.61%9.57M-18.67%10.12M16.92%11.02M32.27%45.72M76.61%14.7M-0.79%9.15M116.06%12.45M
Selling and administrative expenses -44.73%4.02M-12.96%23.01M-34.97%4.2M-2.55%6.05M-30.17%5.49M23.13%7.27M43.48%26.43M79.43%6.45M8.67%6.2M194.79%7.87M
-General and administrative expense -44.73%4.02M-12.96%23.01M-34.97%4.2M-2.55%6.05M-30.17%5.49M23.13%7.27M43.48%26.43M79.43%6.45M8.67%6.2M194.79%7.87M
Research and development costs 20.79%4.75M-15.12%17.77M-52.47%4.19M34.70%4.27M8.63%5.37M-1.60%3.93M20.16%20.93M83.62%8.82M-11.80%3.17M33.24%4.95M
Other operating expenses 48.65%-95K-30.38%-2.15M17.88%-473K-230.09%-746K-101.90%-745K61.22%-185K-28.83%-1.65M-638.46%-576K-175.61%-226K40.58%-369K
Operating profit 21.29%-8.67M16.31%-38.26M46.14%-7.92M-4.61%-9.57M21.62%-9.75M-16.92%-11.02M-68.47%-45.72M-108.50%-14.7M-1.80%-9.15M-6,450.00%-12.45M
Net non-operating interest income expense -35.91%307K14.78%1.92M-21.34%398K-24.44%476K147.81%565K56.03%479K322.80%1.67M23.41%506K5,827.27%630K134.76%228K
Non-operating interest income -50.38%327K-28.54%2.17M-52.21%421K-48.73%504K5.37%589K6.81%659K42.70%3.04M15.47%881K42.67%983K49.87%559K
Non-operating interest expense -88.89%20K-81.39%255K-93.87%23K-92.07%28K-92.75%24K-41.94%180K-52.45%1.37M6.23%375K-49.57%353K-67.83%331K
Other net income (expense) 170.03%1.65M-800.25%-5.54M-97.65%168K131.91%2.07M-14,181.58%-5.43M-1,523.64%-2.35M137.45%791K338.15%7.15M-363.04%-6.48M95.80%-38K
Gain on sale of security 170.03%1.65M-800.25%-5.54M-97.65%168K131.91%2.07M-14,181.58%-5.43M-1,523.64%-2.35M137.63%791K338.47%7.15M-363.04%-6.48M95.80%-38K
Income before tax 47.86%-6.72M3.18%-41.88M-4.33%-7.35M53.18%-7.02M-19.27%-14.62M-43.97%-12.89M-44.19%-43.25M26.92%-7.05M-129.69%-15M-599.89%-12.26M
Income tax 0000000000
Net income 47.86%-6.72M3.18%-41.88M-4.33%-7.35M53.18%-7.02M-19.27%-14.62M-43.97%-12.89M-46.79%-43.25M22.65%-7.05M-129.69%-15M-599.89%-12.26M
Net income continuous Operations 47.86%-6.72M3.18%-41.88M-4.33%-7.35M53.18%-7.02M-19.27%-14.62M-43.97%-12.89M-46.79%-43.25M22.65%-7.05M-129.69%-15M-599.89%-12.26M
Minority interest income
Net income attributable to the parent company 47.86%-6.72M3.18%-41.88M-4.33%-7.35M53.18%-7.02M-19.27%-14.62M-43.97%-12.89M-46.79%-43.25M22.65%-7.05M-129.69%-15M-599.89%-12.26M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 47.86%-6.72M3.18%-41.88M-4.33%-7.35M53.18%-7.02M-19.27%-14.62M-43.97%-12.89M-46.79%-43.25M22.65%-7.05M-129.69%-15M-599.89%-12.26M
Basic earnings per share 50.00%-0.0516.67%-0.250.00%-0.0550.00%-0.050.00%-0.1-100.00%-0.1-50.00%-0.30.00%-0.05-100.00%-0.1-617.77%-0.1
Diluted earnings per share 50.00%-0.0516.67%-0.250.00%-0.0550.00%-0.050.00%-0.1-100.00%-0.1-50.00%-0.30.00%-0.05-100.00%-0.1-617.77%-0.1
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +36.66%
Sample Name
Sample Code
 +24.88%
Sample Name
Sample Code
 -11.95%
4
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
-12.77%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
-15.96%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +15.13%
Sample Name
Sample Code
 +9.15%
Sample Name
Sample Code
 +5.97%
4
Futu Holdings Ltd
FUTU
+3.99%
5
Amer Sports
AS
+3.97%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On June 18, 2026, U.S. President Trump announced that a U.S.-Iran memorandum of understanding had been signed at the Palace of Versailles, w Show More
美伊和平曙光初現！全球市場「拆彈式狂歡」：誰在帶頭衝鋒，升势還能跑多遠？
After the U.S.-Iran memorandum of understanding, crude oil dropped 5%, and my first instinct was to check calls on airline stocks

- No more -